Inflammatory bowel disease biologic blunts immune response to COVID-19, study finds

Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response to COVID-19 infection, new research indicates. View original article here Source

Recommended For You

About the Author: GetFit